U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Conversations on Cancer Black History Month Panel Discussion, “Living with Cancer While Black Clinical Trial Barriers, Part Two” - 02/18/2021 - 02/18/2021
  1. FDA Meetings, Conferences and Workshops


Event Title
Conversations on Cancer Black History Month Panel Discussion, “Living with Cancer While Black Clinical Trial Barriers, Part Two”
February 18, 2021

February 18, 2021
1:00 PM - 2:30 PM ET
Organized By:
Sponsored By:

Twitter: #OCEProjectCommunity


Nadine J. Barrett, PhD., MA., MS - Assistant Professor, Department of Family Medicine and Community Health, Duke School of Medicine 

'Lola Fashoyin-Aje, MD, MPH - Deputy Division Director, Office of Oncologic Diseases, Center for Drug Evaluation and Research, FDA & Associate Director of Scientific and Policy Initiatives to Address Disparities in Drug Development, Oncology Center of Excellence, FDA 

Mel Mann, MBA, M.Ed. - Chronic Myeloid Leukemia Survivor & Patient Advocate Promoting Clinical Trial Participation 

Lori Pierce, MD - President, American Society of Clinical Oncology 

Lori Wilson, MD - Chief of the Division of Surgical Oncology and Program Director of the General Surgical Residency, Howard University Hospital & Cancer Survivor 

Robert Winn, MD - Director, NCI-designated Massey Cancer Center, Virginia Commonwealth University 


Rea Blakey, Associate Director for External Outreach and Engagement in the Oncology Center of Excellence, FDA 


Does a Black cancer patient have equal access to clinical trial participation? How is a patient’s cancer treatment and chance of survival different if they are a Black American? What actions can we each take to contribute to greater equity in the treatment of all Americans with cancer? 

Be sure to join this lively Oncology Center of Excellence panel discussion. 

This 1.5-hour conversation revisits the panel discussion held in July 2020 by further exploring the experiences of Black patients, healthcare researchers, and healthcare providers in the oncology space, along with discussion regarding obstacles for inclusion in cancer clinical trials and efforts to achieve health equity.

Webcast Information: 
A free-of-charge webcast of this panel discussion will be provided. Registration for the webcast is required at the link above. 

FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available. 

For additional information, please send an email to: OCE-Engagement@fda.hhs.gov

Back to Top